Home › Research › Topics › rapidly-progressive
rapidly-progressive
3 studies tagged rapidly-progressive, dated 2017-03-04 to 2023-10-19. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Levels of plasma brain-derived tau and p-tau181 in Alzheimer's disease and rapidly progressive dementias 2023-10-19
- The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias 2018-01-11
- Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease 2017-03-04
Studies
3 studies carry this tag.
Date range
2017 to 2023
Top journals
- Acta neuropathologica 1
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Alzheimer's research & therapy 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Plasma BD-tau and p-tau181 mimic their corresponding cerebrospinal fluid (CSF) markers.
-
The present data indicate that CSF NfL and t-tau levels reflect distinct pathophysiological mechanisms of neurodegeneration and support the clinical use of NfL as a fast screening biomarker for the differential diagnosis of atypical/rapidly progressive NDs.
-
48/100
Rapidly progressive Alzheimer's disease (rpAD) is a particularly aggressive form of Alzheimer's disease, with a median survival time of 7-10 months after diagnosis.